Oxford Biodynamics rolls out EpiSwitch PSE prostate cancer test in US
Developed based on the company’s unique EpiSwitch 3D genomics platform, the EpiSwitch Prostate Screening (PSE) test runs alongside…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Sep 23
Developed based on the company’s unique EpiSwitch 3D genomics platform, the EpiSwitch Prostate Screening (PSE) test runs alongside…
27 Sep 23
Tapestri is a single-cell measurable residual disease (MRD) test intended to provide deep genotypic and immunophenotypic insights into…
27 Sep 23
The world’s first such robotic platform is intended to ease ear, nose, and throat surgical procedures, including instrument…
27 Sep 23
The FDA approval expands the surgical applications of MONTAGE, a unique mouldable bone putty that was previously approved…
27 Sep 23
Patients implanted with the Evoke System now eligible for full-body MRI scans
27 Sep 23
Surgeons at Baptist Health successfully perform weight loss surgery using a revolutionary surgical robotics system.
26 Sep 23
SOMNUM is a sleep disorders analysis software, developed using explainable medical AI (XAI) technology and integrates the latest…
26 Sep 23
The acquisition of Lima is expected to strengthen Enovis’ reconstructive business and help expand the latter’s global presence…
26 Sep 23
Adela intends to use the proceeds from the financing to advance its technology platform and commercialise its first…
26 Sep 23
Thermal Boost is the firm’s first FDA-cleared TULSA AI module which enables predictable, tailored ablation at the prostate…